ACRO BIOMEDICAL CO., LTD. Deferred Tax Assets, Operating Loss Carryforwards
ACRO BIOMEDICAL CO., LTD. (ACBM) had Deferred Tax Assets, Operating Loss Carryforwards of $6.89 million as of 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-11
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.89M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.87M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.86M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $5.01M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $6.89M 10-K · filed 2026-02-11 | |
| 2024-12-31 | $6.87M 10-K · filed 2026-02-11 | |
| 2023-12-31 | $6.86M 10-K · filed 2025-07-24 | |
| 2022-12-31 | $5.01M 10-K · filed 2025-07-18 | |
| 2021-12-31 | $1.68M 10-K · filed 2023-07-21 | |
| 2021-09-30 | $91.35K 10-Q · filed 2021-11-22 | |
| 2021-06-30 | $76.23K 10-Q · filed 2021-08-23 | |
| 2021-03-31 | $78.61K 10-Q · filed 2021-05-24 | |
| 2020-12-31 | $66.64K 10-K · filed 2022-04-15 | |
| 2020-09-30 | $50.33K 10-Q · filed 2020-11-17 | |
| 2020-06-30 | $39.25K 10-Q · filed 2020-08-19 | |
| 2020-03-31 | $39.25K 10-Q · filed 2020-05-19 | |
| 2019-12-31 | $39.25K 10-K · filed 2021-04-02 | |
| 2019-09-30 | $23.41K 10-KT · filed 2020-03-27 | |
| 2019-06-30 | $9.87K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $65.06K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $19.94K 10-KT · filed 2020-03-27 | |
| 2018-09-30 | $32.04K 10-KT · filed 2020-03-27 | |
| 2017-12-31 | $32.04K 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $32.04K 10-K · filed 2018-12-28 | |
| 2016-09-30 | $31.28K 10-K/A · filed 2018-01-16 | $30.21K 10-K · filed 2016-12-16 |
| 2015-09-30 | $16.51K 10-K · filed 2016-12-16 |